Cannabis Law Report

OCTOBER 14, 2021

formerly the Canadian Association of Retired Persons), Canada’s largest advocacy association for Canadians As We Age. Understanding the utility of medical cannabis is increasingly important to older Canadians for the treatment of conditions including chronic pain, anxiety and lack of sleep. ’s advocacy. Most C.A.R.P.

Advocacy 52

Advocacy Research and Development Chronic Pain Pharmaceutical 52

NORML

NOVEMBER 8, 2019

Polling from the American Legion shows that nearly 1 in 4 veterans consume marijuana to alleviate symptoms of a medical or physical condition. Prohibiting VA doctors from recommending cannabis to qualifying patients, while continuing to rely on pharmaceuticals drugs like opioids as a treatment, is both a dangerous and illogical policy.

Access 209

Access Marijuana Treatment Legislation 209

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

Cannabis Law Report

DECEMBER 22, 2019

With a clear passion for cannabis advocacy, Aurora is grateful for his contributions to the company’s growth and role as a global medical cannabis leader. CSE: CHOO), CTT Pharmaceuticals (OTCC: CTTH), Alcanna Inc. Mr. Battley has earned the reputation as a formidable leader and advocate in Canada and beyond.

Research and Development 59

Research and Development Wellness and Beauty Pharmaceutical Events 59

Cannabis Law Report

JUNE 26, 2019

I am a medical patient in Florida’s Medical Marijuana Use Registry due my qualifying condition: a 2010 diagnosis of aggressive Multiple Sclerosis. I used to be a pharmaceutical statistic of opiate and controlled substance pain medications, alongside 25 other Multiple Sclerosis symptom-fighting medications for seven long years.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

NORML

JANUARY 11, 2019

The measure would allow Virginia’s licensed practitioners to recommend and pharmaceutical processors to dispense full therapeutic-strength medical cannabis oil. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. New Mexico. NM resident?

Legislation 195

Legislation Decriminalization Hemp Patients 195

NORML

FEBRUARY 1, 2019

Legislation has been reintroduced from last year, Senate Bill 34, which would exempt compassionate care programs from paying state cannabis taxes when they are providing free medical cannabis to financially disadvantaged people living with serious health conditions. Last session, the measure was vetoed by Governor Brown. CA resident?

Legislation 165

Legislation Decriminalization Access Patients 165

Veriheal

AUGUST 31, 2020

Essay Summary: Although doctors’ offices are full of pamphlets and flyers about mainstream pharmaceuticals in both English and Spanish, there is a lack of information for Hispanic patients seeking relief with cannabis and CBD. . Essay: “Combining Social Sciences and Pharmacology to Make a Positive Social Impact in Cannabis” .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

APRIL 22, 2019

Under current federal and state legislation, patients suffering from severe health conditions can legally access prescription-based medicinal cannabis in Australia. Other conditions listed within Thai medicinal cannabis regulations include migraines, menstrual cramps, concussion and ADHD.

Chronic Pain 10

Chronic Pain Medicine Conditions Access 10

SMPL

MAY 26, 2020

And because CBD doesn’t get you high, it was easy to miss; hardly anyone outside of pharmaceutical companies and academia had heard of it. Mr. Gardner, the writer whose CBD advocacy eventually inspired the 2011 summit at Ms. Police raids and federal prosecution of medical marijuana businesses were still common.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

NORML

JANUARY 24, 2019

The bill would also allow Virginia’s licensed pharmaceutical processors to dispense medical cannabis preparations beyond the current definition of “oil” and in doses proven effective for the variety of disease processes for which doctors will recommend these therapies.

Policy 160

Policy Patients Education Legislation 160

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. Spasticity from neurological conditions. Background. Conclusions. Bonini et al.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

DECEMBER 2, 2021

Cookies also actively works to enrich communities disproportionately impacted by the War on Drugs through advocacy and social equity initiatives. The company offers a collection of over 70 proprietary cannabis strains and more than 2,000 products.

Supply Chain 52

Supply Chain Seed-To-Sale Media Events 52

Cannabis Law Report

SEPTEMBER 10, 2019

Instead, CBD is fast garnering a reputation in the medical world as a potentially soothing treatment for conditions like arthritis, epilepsy , mental stress, or muscle pain, even as for certain forms of cancer.). (Don’t confuse CBD with THC! That’s the chemical in cannabis with the psychoactive effects. Bankers turning to cannabis.

CBD 45

CBD Wellness and Beauty Banking Epilepsy 45

The Cannigma

MAY 7, 2021

In Europe, Murphy explains, cannabis products are held to the same standards of accountability and repeatability as other pharmaceuticals. What do those more pharmaceutical standards mean for patients? MSO: Obviously, every country is different but within Europe and certain rainy islands close to it.

Supply Chain 120

Supply Chain Patients Access Hemp 120

The Cannigma

DECEMBER 22, 2021

At the moment, you said that they could potentially add more conditions. What conditions, or indications can doctors prescribe for in Israel at the moment? IR: Well, today, there is a closed list, basically, of conditions. It also doesn’t include doctor education and research into different conditions.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

NORML

MARCH 14, 2019

Blumenauer said, “For too long, our veterans have been denied access to highly effective medical marijuana treatment for conditions like chronic pain and PTSD. Medical marijuana has shown proven benefits for treating these conditions denying our veterans access to them is shameful. Send a message now to your lawmakers.

Access 215

Access Chronic Pain Treatment Conditions 215

Cannabis Law Report

JUNE 4, 2021

David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Healing Advocacy Fund. Jonathan is the CEO and founder of Gilgamesh Pharmaceuticals. in/carhart-harris-robin-19112542/ [link]. David Nutt. Drug Science.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

The Cannigma

DECEMBER 8, 2021

Then from there, you can get them to, “Okay, it can help with a variety of medical conditions.” We’re here today with Debbie Churgai, the Executive Director of the Americans for Safe Access, one of the longest standing advocacy organizations around medical cannabis in the United States. Thanks for joining us today, Debbie.

Access 81

Access Policy Patients Cannabis 81

The Cannigma

JANUARY 19, 2022

Today on the show we welcome Nikki Lawley, a Traumatic Brain Injury Survivor, and founder of NIKKI and the Plant, an advocacy group for medical marijuana use, with a special focus on helping women who have suffered a TBI. Nikki’s story is deeply inspirational, and we are honored to have had her on the show. Honestly, it was trial and error.

Patients 83

Patients Compliance Compliance Cannabis 83

NORML

JANUARY 25, 2019

Opioid dependency was added to New Jersey’s list of conditions for medical cannabis eligibility. The measure would allow Virginia’s licensed practitioners to recommend and pharmaceutical processors to dispense full therapeutic-strength medical cannabis oil.

Legislation 152

Legislation Patients Oil Hemp 152

NORML

FEBRUARY 8, 2019

Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. The measure would allow Virginia’s licensed practitioners to recommend and pharmaceutical processors to dispense full therapeutic-strength medical cannabis oil.

Legislation 176

Legislation Decriminalization Patients Access 176

Cannabis Law Report

SEPTEMBER 22, 2019

Knowing Your Rights , provided by the national medical cannabis advocacy organization Americans for Safe Access, admonishes current cannabis consumers: Medical cannabis patients and their providers are vulnerable to federal and state raids, arrest, prosecution, and incarceration. PERSONAL RIGHTS.

Cannabis 45

Cannabis Access Patients Legalization 45

Cannabis Law Report

JULY 30, 2019

Patients carefully consider a choice of cannabis physician based on their personal past health, their qualifying condition, and their current health needs: essentially, patients decide which physician can serve that patient’s needs by adding cannabis as a therapeutic medication. .

Marijuana 45

Marijuana Patients Research and Development Programs 45

NORML

AUGUST 26, 2019

There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. The 2017 expansion of Virginia’s medical marijuana law got rid of qualifying conditions. So, we set about these two objectives, one being to add additional conditions.

Marijuana 213

Marijuana Legalization Programs Oil 213